Structures by: Richeson D.
Total: 31
C32H27BrClN2P
C32H27BrClN2P
Inorganica Chimica Acta (2012) 392, 5-9
a=10.836(4)Å b=21.630(8)Å c=23.468(8)Å
α=90.00° β=90.00° γ=90.00°
C23H16F3N4O5ReS
C23H16F3N4O5ReS
Chemical Communications (2019)
a=7.3001(2)Å b=14.2559(4)Å c=22.3731(6)Å
α=90° β=98.9490(10)° γ=90°
C47H55Br2MnN3
C47H55Br2MnN3
Dalton transactions (Cambridge, England : 2003) (2016) 45, 36 14327-14334
a=10.3075(3)Å b=17.9552(6)Å c=23.3943(8)Å
α=90.00° β=96.0330(10)° γ=90.00°
C47H55Br2CoN3
C47H55Br2CoN3
Dalton transactions (Cambridge, England : 2003) (2016) 45, 36 14327-14334
a=10.1944(3)Å b=17.8757(5)Å c=23.3736(6)Å
α=90.00° β=95.9590(10)° γ=90.00°
C47H55Br2N3Ni
C47H55Br2N3Ni
Dalton transactions (Cambridge, England : 2003) (2016) 45, 36 14327-14334
a=10.2419(12)Å b=17.972(2)Å c=23.493(3)Å
α=90° β=95.616(2)° γ=90°
C48.5H58Br2Cl3CuN3
C48.5H58Br2Cl3CuN3
Dalton transactions (Cambridge, England : 2003) (2016) 45, 36 14327-14334
a=15.461(9)Å b=20.210(6)Å c=17.440(5)Å
α=90.00° β=115.478(15)° γ=90.00°
C53H60Br2ClN3Zn
C53H60Br2ClN3Zn
Dalton transactions (Cambridge, England : 2003) (2016) 45, 36 14327-14334
a=16.3022(10)Å b=20.3682(13)Å c=16.9832(11)Å
α=90° β=117.314(4)° γ=90°
C22H21Cl4N4O4Re
C22H21Cl4N4O4Re
Dalton Trans. (2017)
a=10.758(3)Å b=10.896(3)Å c=11.559(3)Å
α=85.079(14)° β=81.257(15)° γ=83.576(15)°
C44H38F6N8O13Re2S2
C44H38F6N8O13Re2S2
Dalton Trans. (2017)
a=16.8249(14)Å b=24.919(2)Å c=12.1149(10)Å
α=90° β=90° γ=90°
2,6-{Ph2PNMe}2(NC5H3)]AgOTf
C32H29AgF3N3O3P2S
Dalton transactions (Cambridge, England : 2003) (2015) 44, 44 19153-19162
a=9.3561(3)Å b=10.9493(4)Å c=16.0927(6)Å
α=100.4111(16)° β=95.3133(16)° γ=96.2905(17)°
2,6-{Ph2PNMe}2(NC5H3)]CuBr
C31H29BrCuN3P2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 44 19153-19162
a=9.2941(5)Å b=11.2624(7)Å c=14.7425(9)Å
α=83.4485(10)° β=86.2809(9)° γ=68.4462(9)°
2,6-{Ph2PNMe}2(NC5H3)]CuOTf
C32H29CuF3N3O3P2S
Dalton transactions (Cambridge, England : 2003) (2015) 44, 44 19153-19162
a=9.5696(2)Å b=13.5271(3)Å c=14.0741(3)Å
α=110.7287(10)° β=105.7160(10)° γ=95.9328(10)°
2,6-{Ph2PNMe}2(NC5H3)](AuCl)2
C31H29Au2Cl2N3O0P2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 44 19153-19162
a=10.981(3)Å b=16.883(4)Å c=16.996(4)Å
α=90° β=102.999(5)° γ=90°
C19H12Cl4N3O3Re
C19H12Cl4N3O3Re
Dalton transactions (Cambridge, England : 2003) (2016) 45, 21 8885-8896
a=9.8736(4)Å b=14.8202(4)Å c=16.3472(4)Å
α=69.2890(10)° β=80.801(2)° γ=79.836(2)°
C25H20Cl4N3O3Re
C25H20Cl4N3O3Re
Dalton transactions (Cambridge, England : 2003) (2016) 45, 21 8885-8896
a=8.5868(2)Å b=10.8679(2)Å c=15.2298(4)Å
α=83.2090(10)° β=75.0400(10)° γ=88.3260(10)°
C24H19BrN3O3Re
C24H19BrN3O3Re
Dalton transactions (Cambridge, England : 2003) (2016) 45, 21 8885-8896
a=8.2910(2)Å b=12.2983(3)Å c=12.6178(3)Å
α=67.1220(10)° β=85.8827(11)° γ=79.6549(11)°
C28H27ClN3O3Re
C28H27ClN3O3Re
Dalton transactions (Cambridge, England : 2003) (2016) 45, 21 8885-8896
a=8.0180(2)Å b=9.6338(3)Å c=17.7434(5)Å
α=84.346(2)° β=87.266(2)° γ=71.691(2)°
C72.5H87Cl3N6O6Re2
C72.5H87Cl3N6O6Re2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 21 8885-8896
a=15.5780(7)Å b=31.7032(14)Å c=15.4332(7)Å
α=90° β=111.164(2)° γ=90°
C18H11BrN3O3Re
C18H11BrN3O3Re
Dalton transactions (Cambridge, England : 2003) (2016) 45, 21 8885-8896
a=31.1537(7)Å b=7.1176(2)Å c=16.8519(4)Å
α=90° β=111.0230(10)° γ=90°
C23H19ClN3O2Re
C23H19ClN3O2Re
Dalton transactions (Cambridge, England : 2003) (2016) 45, 21 8885-8896
a=11.6013(7)Å b=12.4262(7)Å c=15.5501(9)Å
α=90° β=100.114(2)° γ=90°
C28H28BrCl3N3O2Re
C28H28BrCl3N3O2Re
Dalton transactions (Cambridge, England : 2003) (2016) 45, 21 8885-8896
a=13.6894(3)Å b=14.7004(4)Å c=15.2437(4)Å
α=90° β=90° γ=90°
C36H24Cl8N6O4Re2
C36H24Cl8N6O4Re2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 21 8885-8896
a=8.5275(3)Å b=14.2521(5)Å c=17.4637(6)Å
α=77.948(2)° β=85.684(2)° γ=79.890(2)°
C28H28Cl4N3O2Re
C28H28Cl4N3O2Re
Dalton transactions (Cambridge, England : 2003) (2016) 45, 21 8885-8896
a=13.5989(4)Å b=14.5801(4)Å c=15.3708(4)Å
α=90° β=90° γ=90°
<i>N</i>,<i>N</i>',<i>N</i>''-Tricyclohexylguanidinium iodide
C19H36N3,I
Acta Crystallographica Section E (2011) 67, 12 o3467
a=12.893(4)Å b=12.893(4)Å c=12.893(4)Å
α=90.00° β=90.00° γ=90.00°
Bis(<i>N</i>,<i>N</i>',<i>N</i>''-triisopropylguanidinium) fumarate--fumaric acid (1/1)
2(C10H24N3),C4H2O42,C4H4O4
Acta Crystallographica Section E (2012) 68, 6 o1906
a=9.714(3)Å b=11.633(3)Å c=16.226(4)Å
α=90.00° β=102.291(4)° γ=90.00°
C15H26BrN3
C15H26BrN3
Crystal Growth & Design (2005) 5, 5 1881
a=7.991(4)Å b=18.379(9)Å c=11.456(6)Å
α=90.00° β=91.82(3)° γ=90.00°
C10H24ClN3
C10H24ClN3
Crystal Growth & Design (2005) 5, 5 1881
a=11.5301(16)Å b=11.5301(16)Å c=11.5301(16)Å
α=90.00° β=90.00° γ=90.00°
C10H26BrN3O
C10H26BrN3O
Crystal Growth & Design (2005) 5, 5 1881
a=9.6903(12)Å b=9.6903(12)Å c=34.257(6)Å
α=90.00° β=90.00° γ=90.00°
C15H26ClN3
C15H26ClN3
Crystal Growth & Design (2005) 5, 5 1881
a=11.978(2)Å b=37.836(6)Å c=14.948(3)Å
α=90.00° β=90.00° γ=90.00°
C47H55Br2FeN3
C47H55Br2FeN3
Dalton transactions (Cambridge, England : 2003) (2016) 45, 36 14327-14334
a=10.1990(2)Å b=17.8294(4)Å c=23.3592(5)Å
α=90.00° β=96.0360(10)° γ=90.00°
C28H27BrN3O3Re
C28H27BrN3O3Re
Dalton transactions (Cambridge, England : 2003) (2016) 45, 21 8885-8896
a=8.1121(2)Å b=9.8192(3)Å c=17.6928(5)Å
α=84.7500(16)° β=87.4045(15)° γ=72.1162(14)°